Investor Presentation via Engage Investor

AI SummaryClose X

Coiled Therapeutics plc announced that its leadership team will host a live interactive presentation on the Engage Investor Platform on Tuesday, October 6, 2026, at 3:00 PM BST. The presentation will provide an update on the company's clinical development program and strategic progress, with opportunities for investors to submit questions in advance or during the event. The company is a clinical-stage precision oncology firm developing small molecule therapies for genetically defined cancers, with its lead program AO-252 being a TACC3 inhibitor currently in a Phase I clinical trial.

Disclaimer*

UK 100

Latest directors dealings